Vice President, Business Development & New Product Assessment
Bipin Dalmia is responsible for all Ferring U.S. business development activities and is a key member of the Ferring Global Business Development group. Bipin has over 25 years of experience in pharmaceuticals and biotechnology industries, starting as a research scientist and transitioning early in his career to licensing and business development. Before joining Ferring in 2012, he held roles of rapidly increasing responsibilities at Biolex Therapeutics, Syngenta and Novartis. During his 20-year business development career, he has led to conclusion over 50 transactions, both on the buy and sell sides, in biotech, specialty pharma and big pharma across several therapeutic areas and development stages. Bipin holds an MBA degree from Drake University in Des Moines, Iowa, and a Ph.D. in Chemical Engineering from Iowa State University in Ames, Iowa.